SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: vestor who wrote (1245)5/22/1999 6:41:00 PM
From: bw  Read Replies (2) | Respond to of 1837
 
Hi all...Not sure if this ad arrangement was mentioned previously, but if Duramed still has these folks in charge, then expect a really strong marketing campaign to begin soon. The first article is about Gillespie handling the Duramed account:
directmag.com
And here is the heavyweight [IPG] that is behind Gillespie:
themotleyfool.com



To: vestor who wrote (1245)5/22/1999 11:04:00 PM
From: Richaaard  Respond to of 1837
 
The osteoporosis and the long term use questions are the only things keeping Premarin #1 right now. Even AHP wouldn't bet against the resolution of this in DRMD's favor IMO. What will AHP use as a marketing point once these issues are laid to rest? What benefits to horse piss will they then latch onto? It's laughable when you think about it.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News